Get the Stockscreener App
56.63
4.43%
2.40
Pre-market:
56.63
Bruker Corp stock is traded at $56.63, with a volume of 3.50M.
It is up +4.43% in the last 24 hours and up +32.07% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$54.23
Open:
$54.76
24h Volume:
3.50M
Relative Volume:
1.43
Market Cap:
$8.62B
Revenue:
$3.46B
Net Income/Loss:
$-9.40M
P/E Ratio:
-235.57
EPS:
-0.2404
Net Cash Flow:
$51.30M
1W Performance:
+0.66%
1M Performance:
+32.07%
6M Performance:
+24.00%
1Y Performance:
+47.86%
1-Day Range:
$53.48
$56.68
1-Week Range:
$52.90
$58.58
52-Week Range:
$28.53
$64.54
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
56.63 | 8.62B | 3.46B | -9.40M | 51.30M | -0.2404 |
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-09-25 | Initiated | Goldman | Sell |
| Nov-20-25 | Initiated | Rothschild & Co Redburn | Buy |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker Corp (BRKR) Stock Up 4.4% and Still Undervalued -- GF Score: 85/100 - GuruFocus
Broker Technologies (BRKR) files Form 144 to sell 2,000 shares (06/15/2026) - Stock Titan
Bruker Q2 2025 Earnings Preview - MSN
Bruker Corporation (NASDAQ: BRKR) files S-3 shelf for equity, debt and resale offerings - Stock Titan
Bruker Corp (BRKR) Stock Down 4.0% -- Now Undervalued? GF Score: 85/100 - GuruFocus
What Bruker (BRKR)'s Expanded Diagnostics and Energy-Research Tools Portfolio Means For Shareholders - Yahoo Finance
BRKR News | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker advances 4D proteomics, functional proteoform analysis and hybrid metabolomics at ASMS 2026 - Select Science
J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $65 - 富途牛牛
Is Bruker Corporation (BRKR) A Good Stock To Buy Now? - Yahoo Finance
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam - Yahoo Finance
BRKR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Legal & General Group Plc Sells 43,599 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corporation (NASDAQ:BRKR) Given Average Rating of "Hold" by Brokerages - MarketBeat
Bruker (BRKR) Up 37.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Bruker (BRKR) Showcases Innovations in Microbiology at ASM Micro - GuruFocus
Bruker (BRKR) Advances Microbial Diagnostics at ASM Microbe 2026 - GuruFocus
Bruker showcases expanded microbiology diagnostics portfolio By Investing.com - Investing.com Canada
Bruker showcases expanded microbiology diagnostics portfolio - Investing.com
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026 - Caledonian Record
Bruker Corporation $BRKR Shares Bought by BNP Paribas Financial Markets - MarketBeat
Is Bruker Corp (BRKR) Overvalued After 9.4% Rally? GF Value Says - GuruFocus
Bruker shares jump as new ASMS launches spotlight proteomics, energy, and semiconductor demand - Quiver Quantitative
Bruker Corp. Hits New 52-Week High at USD 58.98 - MarketsMojo
Bruker Corp. Hits Day High with 8.27% Surge in Strong Intraday Performance - Markets Mojo
Bruker Corporation Releases timsMRMS Platform for Analysis of Complex Chemical Mixtures - geneonline.com
Bruker launches timsMRMS system for energy research By Investing.com - Investing.com India
Bruker launches timsMRMS system for energy research - Investing.com
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry - Yahoo Finance
BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $65 - 富途牛牛
Bruker’s new tool targets longer-lasting lithium batteries, cleaner fuels - Stock Titan
Wolfe Research Initiates Bruker Corp(BRKR.US) With Hold Rating - Moomoo
Bruker (BRKR) Faces Downgrade from Wolfe Research - GuruFocus
Wolfe Research initiates Bruker stock coverage with Peerperform - Investing.com UK
Wolfe Research initiates Bruker stock coverage with Peerperform By Investing.com - Investing.com Nigeria
Bruker (BRKR) Launches Innovative timsMRMS System - GuruFocus
Is It Time To Consider Buying Bruker Corporation (NASDAQ:BRKR)? - Moomoo
Bruker to pay $3.9844 per share to preferred holders Mar. 2 - Stock Titan
Bruker launches air exposomics tools to link pollution and disease - Stock Titan
Bruker unveils MyGenius PRO diagnostics system - MSN
Bruker Corp. Hits Day High with 11.87% Surge in Strong Performance - Markets Mojo
Bruker Corp stock (US1167941087): valuation focus as shares hover near recent highs - AD HOC NEWS
Bruker (NASDAQ: BRKR) details 2026 vote results and technical 8-K/A update - Stock Titan
Bruker stock hits 52-week high at $56.25 By Investing.com - Investing.com South Africa
Bruker Momentum Builds Across Life Sciences Tools Market - Kalkine Media
Bruker stock hits 52-week high at $56.25 - Investing.com
Q1 Earnings Highs And Lows: Bruker (NASDAQ:BRKR) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Bruker Shares Surge Following Strong (NASDAQ:BRKR) And Analyst Revisions - Kalkine Media
Bruker (NASDAQ:BRKR) Shares Up 9.2%Time to Buy? - MarketBeat
Bruker Corp (BRKR) Stock Up 3.6% and Still Undervalued -- GF Sco - GuruFocus
Bruker (BRKR) Unveils Advanced BioSpec 18T MRI System in Lisbon - GuruFocus
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):